Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China · Delayed Price · Currency is CNY 48.78
+0.79 (1.65%)
At close: Aug 4, 2026
SHA:688193 Market Cap
SHA:688193 has a market cap or net worth of 1.89 billion as of August 4, 2026. Its market cap has decreased by -8.36% in one year.
Market Cap
1.89B
Enterprise Value
1.11B
Revenue
163.34M
Ranking
n/a
PE Ratio
137.35
Stock Price
48.78
ChartMarket Cap Chart
Since March 30, 2022, SHA:688193's market cap has decreased from 2.59B to 1.89B, a decrease of -26.98%. That is a compound annual growth rate of -6.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.89B | 0.85% |
| Dec 31, 2025 | 1.88B | 35.54% |
| Dec 31, 2024 | 1.38B | -23.32% |
| Dec 29, 2023 | 1.80B | -3.42% |
| Dec 30, 2022 | 1.87B | -27.86% |
| Mar 30, 2022 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.73B |
| Shanghai Runda Medical Technology | 6.04B |
| Maccura Biotechnology Co.Ltd | 5.50B |
| Cowealth Medical China | 4.10B |
| Shanghai Labway Clinical Laboratory | 3.50B |
| Guangdong Hybribio Biotech | 3.49B |
| Thalys Medical Technology Group | 3.40B |
| Medicalsystem Biotechnology | 3.32B |